Clearbridge Health logo

Clearbridge Health(SGX) 1H3

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPON/A
5 YearN/A
1 YearN/A
1 MonthN/A
$0.00
+0.00%
+0.00Today

Clearbridge Health Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SGD 14.40M

Net Income (TTM)

-SGD 14.07M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

$0.00

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 19, 2026

1H3 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Clearbridge Health

Clearbridge Health Limited is an investment holding company based in Singapore, specializing in diverse healthcare solutions across multiple regions, including Singapore, the Philippines, Hong Kong, and Malaysia. Established in 2010, the company operates through three main divisions: Strategic Investments, Healthcare Systems, and Medical Clinics/Centres.

Products and Services
  • Advanced imaging diagnostics, including X-ray, CT scans, and MRI
  • General wellness screenings and vaccination programs
  • Specialized care services, including renal treatment and aesthetic procedures
Growth Outlook
  • Expansion into new markets is anticipated to drive revenue growth
  • Increased demand for advanced imaging diagnostics supports service diversification
  • Strategic investments in healthcare technology are expected to enhance operational efficiency
Financial Highlights
  • Recent quarterly revenue of SGD 1,972,000 reflects a strategic focus on core services
  • Trailing twelve months (TTM) gross profit margin stands at 33.97%
  • Current ratio of 3.17 indicates strong short-term financial health
Clearbridge Health Limited is positioned to capitalize on the growing demand for healthcare services in the Asia-Pacific region. The company's diverse offerings in advanced diagnostics and specialized care cater to a wide range of patient needs, enhancing its market presence. Recent financial performance shows a commitment to improving operational efficiency, as evidenced by a solid gross profit margin and a robust current ratio. The strategic focus on expanding into new markets and investing in healthcare technology is expected to drive future growth, making Clearbridge Health an intriguing option for potential investors interested in the healthcare sector.
AI Generated • Oct 1, 2026

Industry

Healthcare Providers and Services

Employees

128

CEO

Jeremy Yee, MBA

Headquarters

Singapore, CE 577177, SG

1H3 Financials

Key Financial Metrics (TTM)

Gross Margin

33.97%

Operating Margin

-32.38%

Net Income Margin

-170.80%

Return on Equity

-237.76%

Return on Capital

-71.66%

Return on Assets

-119.45%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

SGD 5.97M

Operating Income

-SGD 3.03M

EBITDA

-SGD 13.07M

Operating Cash Flow

-SGD 2.68M

Capital Expenditure

-SGD 125.00K

Free Cash Flow

-SGD 2.81M

Cash & ST Invst.

SGD 4.12M

Total Debt

SGD 703.00K

Clearbridge Health Performance Analysis

Clearbridge Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SGD 16,412,00043.4%
20232023-12-31SGD 10,407,000-36.6%
20242024-12-31SGD 9,903,000-4.8%
20252025-12-31SGD 9,929,0000.3%
Clearbridge Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3110.0%
Q22025-06-3096.5%
Q42025-12-312.0%
Q22026-06-30-60.7%
Clearbridge Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SGD -0.01-44.4%
20232023-12-31SGD -0.03189.0%
20242024-12-31SGD -0.01-79.9%
20252025-12-31SGD -0.00-32.8%
Clearbridge Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3161.1%
Q22025-06-30-14.3%
Q42025-12-31-337.5%
Q22026-06-30100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

SGD 1.97M

-13.3%

Gross Profit

-SGD 227.00K

-122.1%

Gross Margin

-11.51%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

113

N/A

Net Income

-SGD 434.00K

+62.7%

EBITDA

-SGD 806.00K

-38.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

SGD 4.12M

+83.4%

Total Debt

SGD 703.00K

-89.6%

Accounts Receivable

SGD 3.71M

+279.4%

Inventory

SGD 191.00K

+7.9%

Long Term Debt

SGD 506.00K

-90.0%

Short Term Debt

SGD 197.00K

-88.5%

Return on Assets

-1.19%

N/A

Return on Invested Capital

-31.05%

N/A

Free Cash Flow

-SGD 195.00K

+91.3%

Operating Cash Flow

-SGD 191.00K

+91.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,709.28-0.01%
^DJIDJI
$51,466.30-0.00%
^IXICNASDAQ
$26,684.28-0.02%
BTCBitcoin
$81,564.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
CCCCCC Intelligent Solutions
$7.62-0.33%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$102.51-7.26%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$45.57+7.16%
INTCIntel
$94.16-4.04%

Questions About 1H3

What is the current price of Clearbridge Health?

Clearbridge Health is trading at N/A per share.

What is the 52-week range for Clearbridge Health?

Over the past 52 weeks, Clearbridge Health has traded between N/A and N/A.

How much debt does Clearbridge Health have?

As of the most recent reporting period, Clearbridge Health reported total debt of SGD 6.24M.

How much cash does Clearbridge Health have on hand?

Clearbridge Health reported SGD 3.17M in cash and cash equivalents in its most recent financial results.

What is Clearbridge Health’s dividend yield?

Clearbridge Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.